Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
GLOBETECH PUBLISHING

A Histone Demethylase Regulates Stem Cell Differentiation

By BiotechDaily International staff writers
Posted on 06 Mar 2013
A recent publication detailed how the protein Fbxl10 regulates the maturation process that takes place when an embryonic stem cell differentiates into a specialized, functional tissue cell.

Fbxl10 is a histone demethylase enzyme that removes a methyl group from lysine-4' and lysine-36' of the histone H3. Preferentially Fbxl10 removes methyl groups from trimethylated H3 lysine-4' and dimethylated H3 lysine-36' residues while it has weak or no activity for mono- or trimethylated H3 lysine-36'. Fbxl10 preferentially binds the transcribed region of ribosomal RNA and represses the transcription of ribosomal RNA genes which inhibits cell growth and proliferation.

In the paper published in the February 7, 2013, online edition of the journal Molecular Cell investigators at the University of Copenhagen (Denmark) found that to regulate stem cell maturation Fbxl10 directly recruits Polycomb Repressive Complex 1 proteins into CpG islands.

Polycomb-group (PcG) proteins are a family of proteins first discovered in fruit flies that can remodel chromatin so that epigenetic silencing of genes takes place. In humans, Polycomb Group gene expression is important in many aspects of development. Mouse mutants lacking PRC2 (Polycomb Repressive Complex 2) genes die as embryos while most PRC1 (Polycomb Repressive Complex 1) mutants are born alive but with anatomic rearrangements that cause them to die shortly after birth. In contrast, overexpression of PcG proteins correlates with the severity and invasiveness of several cancer types.

CpG islands are genomic regions that contain a high frequency of CpG sites. The "p" in CpG refers to the phosphodiester bond between the cytosine and the guanine residues, which indicates that the C and the G are next to each other in sequence, regardless of being single- or double-stranded. In a CpG site, both C and G are found on the same strand of DNA or RNA and are connected by a phosphodiester bond.

“Our new results show that this molecule is required for the function of one of the most important molecular switches that constantly regulates the activity of our genes. If Fbxl10 is not present in embryonic stem cells, the cells cannot differentiate properly, and this can lead to developmental defects,” said Dr. Kristian Helin, professor of health sciences at the University of Copenhagen.

Related Links:
University of Copenhagen




comments powered by Disqus

Channels

Drug Discovery

view channel
Image: Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells (Photo courtesy of the University of Texas, Austin).

Experimental Drug Kills Cancer Cells by Interfering with Their Ion Transport Mechanism

An experimental anticancer drug induces cells to enter a molecular pathway leading to apoptosis by skewing their ion transport systems to greatly favor the influx of chloride anions. To promote development... Read more

Therapeutics

view channel
Image: Liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left (Photo courtesy of Marshall et al, 2014, the Journal of Experimental Medicine).

New Drug Triggers Liver Regeneration After Surgery

Investigators have revealed that an innovative complement inhibitor decreases complement-mediated liver cell death, and actually stimulates postsurgery liver regrowth in mice. Liver cancer often results... Read more

Lab Technologies

view channel

White-Matter Deficits Found in Codeine-Containing Cough Syrup Users

A magnetic resonance imaging (MRI) study of chronic users of codeine-containing cough syrups (CCS) has found deficits in specific regions of brain white matter and linked these changes with increased impulsivity in codeine-containing cough syrup users. These findings were consistent with findings from earlier research of... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.